• 1
    Silverman DI, Burton KJ, Gray J, Bosner MS, Kouchoukos NT, et al.: Life expectancy in the Marfan syndrome. Am J Cardiol 1995; 75: 157160.
  • 2
    Yetman AT, Bornemeier RA, McCrindle BW: Long-term outcome in patients with Marfan syndrome: Is aortic dissection the only cause of sudden death? J Am Coll Cardiol 2003; 41: 329332.
  • 3
    Siracusa LD, McGrath R, Ma Q, Moskow JJ, Manne J, et al.: A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 1997; 6: 300313.
  • 4
    Roberts WC, Honig HS: The spectrum of cardiovascular disease in the Marfan syndrome: A clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients. Am Heart J 1982; 104: 115134.
  • 5
    Gross DM, Robinson LK, Smith LT, Glass N, Rosenberg H, et al.: Severe perinatal Marfan syndrome. Pediatrics 1989; 84: 8389.
  • 6
    James TN, Frame B, Schatz IJ: Pathology of cardiac conduction system in Marfan's syndrome. Arch Intern Med 1964; 114: 339343.
  • 7
    Chen S, Fagan LF, Nouri S, Donahoe JL: Ventricular dysrhythmias in children with the Marfan's syndrome. Am J Dis Child 1985; 139: 273276.
  • 8
    Johnson CD: The Wolff-Parkinson-White syndrome associated with Marfan's syndrome. Bol Assoc Med P Rico 1989; 81: 361364.
  • 9
    von Kodolitsch Y, Rybczynski M. Cardiovascular aspects of the Marfan syndrome—a systematic review. In Marfan Syndrome: A Primer for Clinicians and Scientists (Eds. RobinsonPN, GodfreyM), pp. 4569., Austin and Kluwer Academic/Plenum Publishers, London (ISBN 0-306-48238-X).
  • 10
    De Paepe A, Devereux RB, Dietz HC, Hennekam RCM, Pyeritz RE: Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62: 417426.
  • 11
    Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, et al.: Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001; 104: 128130.
  • 12
    Miller DC: Valve-sparing aortic root replacement in patients with the Marfan syndrome. J Thorac Cardiovasc Surg 2003; 125: 773778.
  • 13
    Schiller NB, Shah PM, Crawford M, De Maria A, Devereux DB, et al.: Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358367.
  • 14
    Freed LA, Levy D, Levine RA, Larson MG, Evans JC, et al.: Prevalence and clinical outcome of mitral valve prolapse. N Engl J Med 1999; 341: 17.
  • 15
    Savolainen S, Nisula L, Keto P, Hekali P, Viitasalo M, et al.: Left ventricular function in children with the Marfan syndrome. Eur Heart J 1994; 15: 625630.
  • 16
    Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J: Two dimensional aortic root dimensions in normal children and adults. Am J Cardiol 1989; 64: 507512.
  • 17
    Porciani M, Giurlani L, Chelucci A, Pepe G, Giusti BH, et al.: Diastolic subclinical primary alterations in Marfan syndrome and Marfan-related disorders. Clin Cardiol 2002; 25: 416420.
  • 18
    Thomas JD, Wyman AE. Echocardiographic Doppler evaluation of the left ventricular diastolic function. Physics and physiology. Circulation 1991; 84: 977990.
  • 19
    Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, et al.: Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 2003; 108: 395397.
  • 20
    Burlew BS, Weber KT: Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin 2000; 18: 435442.
  • 21
    Raghunath M, Superti-Furga A, Godfrey M, Steinmann B: Decreased extracellular deposition of fibrillin and decorin in neonatal Marfan syndrome fibroblasts. Hum Genet 1993; 90: 511515.
  • 22
    Ng CM, Cheng A, Myers L, Martinez-Murillo F, Jie C, et al.: TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004; 114: 15861592.
  • 23
    Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ: Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998; 77: 3137.
  • 24
    Pieroni M, Chimenti C, Ricci R, Sale P, Russo MA, et al.: Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 2003; 107: 19781984.
  • 25
    Pyeritz RE: The Marfan syndrome. Ann Rev Med 2000; 51: 481510.
  • 26
    Hetzer R, Pregla R, Barthel F: Surgery for cardiovascular disorders in Marfan syndrome. In Marfan Syndrome: A Primer for Clinicians and Scientists (Eds. RobinsonPN, GodfreyM), pp 8192., Austin and Kluwer Academic/Plenum Publishers, London (ISBN 0-306-48238-X).